These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma. Lee TF; Chao PJ; Ting HM; Lo SH; Wang YW; Tuan CC; Fang FM; Su TJ J Appl Clin Med Phys; 2011 Nov; 12(4):3587. PubMed ID: 22089015 [TBL] [Abstract][Full Text] [Related]
6. Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRT. Lu SH; Cheng JC; Kuo SH; Lee JJ; Chen LH; Wu JK; Chen YH; Chen WY; Wen SY; Chong FC; Wu CJ; Wang CW Radiother Oncol; 2012 Sep; 104(3):324-30. PubMed ID: 22236614 [TBL] [Abstract][Full Text] [Related]
7. Dosimetric evaluation of automatic and manual plans for early nasopharyngeal carcinoma to radiotherapy. Zhang Q; Peng Y; Song X; Yu H; Wang L; Zhang S Med Dosim; 2020 Spring; 45(1):e13-e20. PubMed ID: 31466735 [TBL] [Abstract][Full Text] [Related]
8. Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals. Zhuang Y; Han J; Chen L; Liu X Phys Med Biol; 2019 Dec; 64(23):23NT03. PubMed ID: 31683261 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of automatic VMAT plans in locally advanced nasopharyngeal carcinoma. Zhang Q; Ou L; Peng Y; Yu H; Wang L; Zhang S Strahlenther Onkol; 2021 Mar; 197(3):177-187. PubMed ID: 32488293 [TBL] [Abstract][Full Text] [Related]
10. A new strategy for volumetric-modulated arc therapy planning using AutoPlanning based multicriteria optimization for nasopharyngeal carcinoma. Wang J; Chen Z; Li W; Qian W; Wang X; Hu W Radiat Oncol; 2018 May; 13(1):94. PubMed ID: 29769101 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy. Ding Z; Xiang X; Zeng Q; Ma J; Dai Z; Kang K; Bi S Radiat Oncol; 2022 Jan; 17(1):1. PubMed ID: 34980178 [TBL] [Abstract][Full Text] [Related]
12. Single arc volumetric-modulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Ning ZH; Mu JM; Jin JX; Li XD; Li QL; Gu WD; Huang J; Han Y; Pei HL Radiat Oncol; 2013 Oct; 8():237. PubMed ID: 24125432 [TBL] [Abstract][Full Text] [Related]
13. Feasibility of constant dose rate VMAT in the treatment of nasopharyngeal cancer patients. Yu W; Shang H; Xie C; Han C; Yi J; Zhou Y; Jin X Radiat Oncol; 2014 Nov; 9():235. PubMed ID: 25366034 [TBL] [Abstract][Full Text] [Related]
14. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Lee TF; Ting HM; Chao PJ; Fang FM Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):196-207. PubMed ID: 21752615 [TBL] [Abstract][Full Text] [Related]
15. Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy. Sun Y; Guo R; Yin WJ; Tang LL; Yu XL; Chen M; Qi ZY; Liu MZ; Ma J PLoS One; 2013; 8(9):e75304. PubMed ID: 24086503 [TBL] [Abstract][Full Text] [Related]
16. The Hippocampus Sparing Volume Modulated Arc Therapy does not Influence Plan Quality on Locally Advanced Nasopharyngeal Carcinoma Patients. Gu W; Li Q; Xi D; Tian Y; Mo J; Pei H Sci Rep; 2017 Jun; 7(1):3443. PubMed ID: 28611367 [TBL] [Abstract][Full Text] [Related]
17. Dosimetric comparison between RapidArc and HyperArc techniques in salvage stereotactic body radiation therapy for recurrent nasopharyngeal carcinoma. Ho HW; Lee SP; Lin HM; Chen HY; Huang CC; Wang SC; Yang CC; Lin YW Radiat Oncol; 2020 Jul; 15(1):164. PubMed ID: 32641082 [TBL] [Abstract][Full Text] [Related]
18. Application of dose-volume histogram prediction in biologically related models for nasopharyngeal carcinomas treatment planning. Cao W; Zhuang Y; Chen L; Liu X Radiat Oncol; 2020 Sep; 15(1):216. PubMed ID: 32933543 [TBL] [Abstract][Full Text] [Related]
19. A bias-free, automated planning tool for technique comparison in radiotherapy - application to nasopharyngeal carcinoma treatments. Boylan C; Rowbottom C J Appl Clin Med Phys; 2014 Jan; 15(1):4530. PubMed ID: 24423853 [TBL] [Abstract][Full Text] [Related]
20. Cochlea sparing optimized radiotherapy for nasopharyngeal carcinoma. Lamaj E; Vu E; van Timmeren JE; Leonardi C; Marc L; Pytko I; Guckenberger M; Balermpas P Radiat Oncol; 2021 Apr; 16(1):64. PubMed ID: 33794949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]